Concepedia

Publication | Closed Access

HER-targeted tyrosine kinase inhibitors enhance response to trastuzumab and pertuzumab in HER2-positive breast cancer

DOI

29

Citations

29

References

2018

Year

Alexandra Canonici, Laura Ivers, Neil T. Conlon, Kasper Pedersen, Nicola Gaynor, Brigid C. Browne, Neil A. O’Brien, Giuseppe Gullo, Denis M. Collins, Norma O’Donovan,
Investigational New Drugs

References

YearCitations

Page 1